5 days ago
VKTX
AnalystsEdward NashEdward Nash's Stock Forecasts
AnalystsEdward Nash
Sectors:
Analyst Ranking
Top 6%
#274 out of 5342 analysts
Average Return
+27.65%
Win Rate
54%60 out of 111
Risk vs Reward
Poor
Good
Edward Nash's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Verona Pharma PLCVRNA | +511.40% | $15.44 | $94.40 | 2024-06-27 - 2025-06-26 | Strong Buy |
Verona Pharma PLCVRNA | +357.91% | $22.88 | $104.77 | 2024-07-22 - 2025-07-09 | Strong Buy |
Cardiol Therapeutics IncCRDL | +267.80% | $0.59 | $2.17 | 2023-05-19 - 2024-05-17 | Strong Buy |
Corcept Therapeutics IncCORT | +199.71% | $38.20 | $114.49 | 2026-01-02 - 2026-07-31 | Strong Buy |
Corcept Therapeutics IncCORT | +197.15% | $38.53 | $114.49 | 2026-03-26 - 2026-07-31 | Strong Buy |
Edward Nash Analyst Color
Get additional color on Edward Nash's coverage of popular stocks
5 days ago
TVTX
5 days ago
CORT
5 days ago
MDGL
5 days ago
KNSA
a month ago
KYMR
2 months ago
CORT
3 months ago
SGMT
3 months ago
KNSA
4 months ago
TVTX
4 months ago
APGE
6 months ago
CORT
9 months ago
MDGL
9 months ago
VKTX
9 months ago
VTYX
a year ago
CORT
a year ago
MDGL
a year ago
MDGL
a year ago
TVTX
a year ago
CORT
a year ago
VRNA
a year ago
TVTX
2 years ago
CORT
2 years ago
AKRO
2 years ago
VRNA
Edward Nash's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | 3 | Strong Buy | $114.00 | +259.17% | Maintains | 5 days ago |
Travere Therapeutics IncTVTX | 12 | Strong Buy | $62.00 | +10.93% | Maintains | 5 days ago |
Corcept Therapeutics IncCORT | 16 | Strong Buy | $161.00 | +40.62% | Maintains | 5 days ago |
Madrigal Pharmaceuticals IncMDGL | 12 | Strong Buy | $587.00 | +25.61% | Maintains | 5 days ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Strong Buy | $98.00 | +31.83% | Maintains | 5 days ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $60.00 | +57.65% | Maintains | 13 days ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $153.00 | +116.50% | Initiates Coverage On | 13 days ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $129.00 | +24.76% | Maintains | a month ago |
Apogee Therapeutics IncAPGE | 3 | Hold | $135.11 | +0.76% | Downgrades | a month ago |
Veru IncVERU | 2 | Strong Buy | $25.00 | +1,016.07% | Maintains | 2 months ago |
Connect Biopharma Holdings LtdCNTB | 1 | Strong Buy | $6.00 | +197.03% | Initiates Coverage On | 2 months ago |
Rani Therapeutics Holdings IncRANI | 4 | Strong Buy | $5.00 | +545.99% | Maintains | 2 months ago |
Sagimet Biosciences IncSGMT | 3 | Strong Buy | $49.00 | +589.17% | Maintains | 3 months ago |
Structure Therapeutics IncGPCR | 1 | Strong Buy | $101.00 | +110.24% | Initiates Coverage On | 3 months ago |
Cardiol Therapeutics IncCRDL | 4 | Strong Buy | $8.00 | +529.92% | Maintains | 4 months ago |
Pliant Therapeutics IncPLRX | 3 | Hold | $3.00 | +188.46% | Maintains | 5 months ago |
Ventyx Biosciences IncVTYX | 8 | Hold | $14.00 | 0.00% | Downgrades | 7 months ago |
Akero Therapeutics IncAKRO | 6 | Hold | $54.00 | -1.19% | Downgrades | 10 months ago |
Inventiva SaIVA | 3 | Strong Buy | $20.00 | +346.43% | Maintains | 10 months ago |
Verona Pharma PLCVRNA | 8 | Hold | $107.00 | N/A | Downgrades | a year ago |
Morphic Holding IncMORF | 2 | Strong Buy | $66.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 7 | Hold | $19.00 | N/A | Downgrades | 3 years ago |
Theratechnologies IncTHTX | 4 | Hold | $8.00 | N/A | Assumes | 3 years ago |
Dice Therapeutics IncDICE | 3 | Hold | $48.00 | N/A | Downgrades | 3 years ago |
Oramed Pharmaceuticals IncORMP | 2 | Hold | $2.00 | N/A | Maintains | 3 years ago |
Amryt Pharma PLCAMYT | 2 | Hold | $17.00 | N/A | Downgrades | 4 years ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Chemocentryx IncCCXI1 | 2 | Hold | $52.00 | N/A | Downgrades | 4 years ago |
Rezolute IncRZLT | 1 | Strong Buy | $17.00 | N/A | Assumes | 4 years ago |
Obseva SaOBSVF | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Metacrine IncMTCR | 1 | Hold | $1.00 | N/A | Downgrades | 5 years ago |
Adverum Biotechnologies IncADVM | 3 | Hold | $80.00 | N/A | Maintains | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $54.00 | N/A | Maintains | 8 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Uniqure NvQURE | 1 | Strong Buy | $48.00 | N/A | Initiates Coverage On | 8 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $650.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.